Medicis won't raise$2.8B Inamed offer

Medicis has chosen not to pursue a buyout of Inamed after offering $2.8 billion for the company in March 2005. Botox-maker Allergan trumped Medicis' by offering to buy Inamed for a substantially higher price--$3.2 billion. Inamed will pay Medicis a $90 million termination fee.

- read this AP report

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.